
Medpace Holdings MEDP
$ 498.64
1.04%
Annual report 2025
added 02-10-2026
Medpace Holdings Operating Cash Flow 2011-2026 | MEDP
Annual Operating Cash Flow Medpace Holdings
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 713 M | 609 M | 433 M | 388 M | 263 M | 259 M | 202 M | 157 M | 97.4 M | 91.7 M | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 713 M | 91.7 M | 321 M |
Quarterly Operating Cash Flow Medpace Holdings
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | 126 M | - | - | - | 153 M | - | - | - | 80.1 M | - | 251 M | - | 46.3 M | - | 192 M | - | 57.3 M | - | 153 M | 93.4 M | 49.1 M | - | 145 M | 80.6 M | 34 M | - | 117 M | 64.6 M | 23.3 M | - | 68.7 M | 29.7 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 251 M | 23.3 M | 98 M |
Operating Cash Flow of other stocks in the Diagnostics research industry
| Issuer | Operating Cash Flow | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
-21.7 M | - | -6.23 % | $ 30.6 M | ||
|
Agilent Technologies
A
|
1.48 B | $ 115.19 | 0.1 % | $ 35 B | ||
|
BioNano Genomics
BNGO
|
-16.3 M | $ 1.14 | 0.44 % | $ 6.21 M | ||
|
Burning Rock Biotech Limited
BNR
|
-478 M | $ 16.2 | 0.56 % | $ 174 M | ||
|
Aspira Women's Health
AWH
|
-7.03 M | - | -6.19 % | $ 10.5 M | ||
|
Biocept
BIOC
|
-13.3 M | - | -13.05 % | $ 7.29 M | ||
|
Chembio Diagnostics
CEMI
|
-12.7 M | - | 0.22 % | $ 16.8 M | ||
|
Check-Cap Ltd.
CHEK
|
-8 M | - | - | $ 9.42 M | ||
|
DermTech
DMTK
|
-77 M | - | -11.32 % | $ 2.94 M | ||
|
CareDx, Inc
CDNA
|
42 M | $ 16.29 | 1.46 % | $ 868 M | ||
|
Akumin
AKU
|
65.4 M | - | -17.87 % | $ 25.9 M | ||
|
Enzo Biochem
ENZ
|
-26.3 M | - | -8.98 % | $ 14.8 K | ||
|
Co-Diagnostics
CODX
|
-29.1 M | $ 1.41 | 2.92 % | $ 1.88 M | ||
|
Exact Sciences Corporation
EXAS
|
491 M | - | - | $ 19.8 B | ||
|
Interpace Biosciences
IDXG
|
5.83 M | $ 2.25 | -2.17 % | $ 9.95 M | ||
|
Accelerate Diagnostics
AXDX
|
-48.7 M | - | -61.36 % | $ 2.46 M | ||
|
Castle Biosciences
CSTL
|
64.9 M | $ 23.05 | -0.35 % | $ 640 M | ||
|
Global Cord Blood Corporation
CO
|
614 M | - | - | $ 399 M | ||
|
Genetic Technologies Limited
GENE
|
-5.66 M | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
-524 M | - | 0.12 % | $ 80.1 M | ||
|
Charles River Laboratories International
CRL
|
738 M | $ 175.38 | -0.17 % | $ 8.69 B | ||
|
Danaher Corporation
DHR
|
6.42 B | $ 190.7 | 0.6 % | $ 136 B | ||
|
Heska Corporation
HSKA
|
-21.8 M | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
-18.4 M | - | -20.0 % | $ 1.06 M | ||
|
Myriad Genetics
MYGN
|
1.8 M | $ 4.47 | 2.64 % | $ 414 M | ||
|
Illumina
ILMN
|
837 M | $ 122.51 | 1.3 % | $ 19.5 B | ||
|
NeoGenomics
NEO
|
5.23 M | $ 7.94 | 3.19 % | $ 1.02 B | ||
|
Fulgent Genetics
FLGT
|
21.1 M | $ 14.95 | 3.57 % | $ 452 M | ||
|
Guardant Health
GH
|
-185 M | $ 78.76 | 0.2 % | $ 9.87 B | ||
|
QIAGEN N.V.
QGEN
|
654 M | - | - | $ 10.6 B | ||
|
Anixa Biosciences
ANIX
|
-7.17 M | $ 2.77 | 2.97 % | $ 89.9 K | ||
|
Biomerica
BMRA
|
-3.84 M | $ 2.07 | -3.19 % | $ 4.75 M | ||
|
Invitae Corporation
NVTA
|
-493 M | - | - | $ 21.2 M | ||
|
ICON Public Limited Company
ICLR
|
1.29 B | $ 107.75 | 0.88 % | $ 8.89 B | ||
|
Laboratory Corporation of America Holdings
LH
|
1.64 B | $ 261.97 | 0.4 % | $ 21.8 B | ||
|
Natera
NTRA
|
-432 M | $ 199.83 | 3.52 % | $ 19.7 B | ||
|
Celcuity
CELC
|
-153 M | $ 118.95 | 1.55 % | $ 5.56 B | ||
|
Senseonics Holdings
SENS
|
-59.1 M | $ 6.67 | -0.15 % | $ 278 M | ||
|
Lantheus Holdings
LNTH
|
390 M | $ 80.99 | 0.5 % | $ 5.47 B | ||
|
Motus GI Holdings
MOTS
|
-11.2 M | - | -34.28 % | $ 263 K | ||
|
Quest Diagnostics Incorporated
DGX
|
1.89 B | $ 192.07 | 0.29 % | $ 21.3 B | ||
|
Soleno Therapeutics
SLNO
|
46.8 M | $ 52.58 | -0.1 % | $ 2.67 B | ||
|
Neogen Corporation
NEOG
|
58.2 M | $ 9.19 | -2.46 % | $ 1.99 B | ||
|
ENDRA Life Sciences
NDRA
|
-5.18 M | $ 5.0 | 1.21 % | $ 3.94 M | ||
|
Organovo Holdings
ONVO
|
-9.46 M | - | -2.3 % | $ 19.4 M |